Guardian Pharmacy Services, Inc.
For the period ended Dec 31, 2025. Filed Mar 11, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 11, 2026
GRDN$49.85+6.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2024 and 2025
CONSOLIDATED BALANCE SHEETS
| December 31, | ||
|---|---|---|
| (In thousands, except share amounts) | 2024 | 2025 |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $4,660 | $65,619 |
| Accounts receivable, net | 97,153 | 101,614 |
| Inventories | 40,550 | 43,359 |
| Other current assets | 9,622 | 11,042 |
| Total current assets | 151,985 | 221,634 |
| Property and equipment, net | 49,883 | 55,522 |
| Intangible assets, net | 14,912 | 18,475 |
| Goodwill | 69,296 | 79,743 |
| Operating lease right-of-use assets | 29,079 | 34,649 |
| Deferred tax assets | 5,272 | 2,199 |
| Other assets | 383 | 436 |
| Total assets | $320,810 | $412,658 |
| Liabilities and equity | ||
| Current liabilities: | ||
| Accounts payable | $102,420 | $116,206 |
| Accrued compensation | 14,430 | 15,048 |
| Operating leases, current portion | 6,836 | 7,150 |
| Other current liabilities | 20,435 | 22,299 |
| Total current liabilities | 144,121 | 160,703 |
| Operating leases, net of current portion | 23,297 | 29,992 |
| Other liabilities | 3,416 | 4,039 |
| Total liabilities | $170,834 | $194,734 |
| Commitments and contingencies (see Note 9) | ||
| Equity: | ||
| Members’ equity | — | — |
| Class A common stock- 700,000,000 shares authorized, par value $0.001; 9,200,000 and 36,253,744 shares issued and outstanding as of December 31, 2024 and December 31, 2025, respectively | 9 | 36 |
| Class B common stock- 100,000,000 shares authorized, par value $0.001; 54,087,158 and 27,066,890 shares issued and outstanding as of December 31, 2024 and December 31, 2025, respectively | 54 | 27 |
| Additional paid-in capital | 125,484 | 139,353 |
| Retained earnings | 17,124 | 66,343 |
| Non-controlling interests | 7,305 | 12,165 |
| Total equity | 149,976 | 217,924 |
| Total liabilities and equity | $320,810 | $412,658 |
See accompanying notes to Consolidated Financial Statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.